To evaluate the anti-lung cancer effect, we estimated three anti-lung cancer biomarkers: Intercellular Adhesion Molecule-1(ICAM-1), MYC proto-oncogene, bHLH transcription factor(c-MYC), and Matrix metalloproteinase-9 (MMP9) genes. The gene discussed is MYC; the disease is lung cancer.